Alzamend Neuro Announces Initiation Date Of Phase II Clinical Trial Of AL001 For Treatment Of Bipolar Disorder To Take Place At Massachusetts General Hospital
ALZAMEND NEURO ANNOUNCES INITIATION DATE OF PHASE II CLINICAL TRIAL OF AL001 FOR TREATMENT OF BIPOLAR DISORDER TO TAKE PLACE AT MASSACHUSETTS GENERAL HOSPITAL
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.